RECURRENT PROSTATE CANCER
Clinical trials for RECURRENT PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE CANCER trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine combo aims to wipe out stubborn prostate cancer spots
Disease control Recruiting nowThis early-stage study is testing whether a new DNA vaccine, combined with an immunotherapy drug (nivolumab) and targeted radiation, can eliminate small areas of recurring prostate cancer that have spread. It's for men whose cancer has returned after prostate surgery but is limit…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE1 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New combo therapy aims to keep recurrent prostate cancer at bay
Disease control Recruiting nowThis study is testing whether adding an immunotherapy injection (PDS01ADC) to a standard prostate cancer pill (enzalutamide) works better than the pill alone for men whose cancer has returned after initial treatment. The goal is to control the cancer and delay its progression for…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Mayo clinic tests if less treatment works just as well for prostate cancer
Disease control Recruiting nowThis study is testing whether less aggressive treatment works as well as more intensive therapy for prostate cancer that has returned or spread. Researchers are comparing different approaches, including targeted radiation alone versus radiation combined with hormone-blocking drug…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
VA launches major trial to see if zapping spots boosts prostate cancer fight
Disease control Recruiting nowThis VA study is testing if adding targeted radiation or surgery to standard drug therapy works better for controlling prostate cancer that has spread to a few spots. It will involve about 464 Veterans whose cancer has returned or spread to 1-10 locations. The goal is to see if t…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2, PHASE3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC
-
Second chance radiation: precision treatment targets prostate Cancer's return
Disease control Recruiting nowThis study tests a targeted radiation treatment for men whose prostate cancer has returned after initial radiation therapy. Using advanced imaging to pinpoint the exact location of the recurrence, doctors deliver a high-dose radiation boost directly to the tumor area. The goal is…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC
-
New scan aims to spot hidden prostate cancer earlier
Diagnosis Recruiting nowThis study is testing a new type of imaging scan called PSMA-PET to see if it can better detect prostate cancer that has returned or spread in men who are at high risk based on a genetic test. It will enroll 60 men who previously had high-risk genetic test results and were treate…
Matched conditions: RECURRENT PROSTATE CANCER
Phase: PHASE2, PHASE3 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Diagnosis
Last updated Mar 18, 2026 14:55 UTC